PIDS

Quanergy Introduces Industry’s First 3D LiDAR Security as a Service Solution

Retrieved on: 
Wednesday, August 16, 2023

SAN JOSE, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Quanergy Solutions, Inc., invites organizations to see beyond the constraints of traditional security sales models with the introduction of the industry’s first Security as a Service (SaaS) model for its revolutionary Q-Track™ 3D LiDAR (Light Detection and Ranging) solution. This yearly subscription option offers enhanced financial flexibility, allowing enterprise users to budget their powerful Q-Track solutions as an operating expense (OPEX) versus a capital expense (CAPEX).

Key Points: 
  • SAN JOSE, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Quanergy Solutions, Inc., invites organizations to see beyond the constraints of traditional security sales models with the introduction of the industry’s first Security as a Service (SaaS) model for its revolutionary Q-Track™ 3D LiDAR (Light Detection and Ranging) solution.
  • “Our vision at Quanergy is to provide real-time, proactive awareness for dynamic environments that demand higher levels of event detection, classification and tracking,” said Enzo Signore, CEO, Quanergy Solutions.
  • Quanergy is offering both the new Security as a Service and traditional CAPEX ownership models, ensuring that customers can choose the option that best aligns with their needs.
  • Quanergy Q-Track 3D LiDAR solutions have already gained recognition as the preferred security solution at over 100 global locations, safeguarding critical infrastructure, smart cities, and smart spaces.

Quanergy Sees Beyond Conventional Physical Security Technology and Business Models

Retrieved on: 
Thursday, August 10, 2023

SAN JOSE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Quanergy Solutions, Inc., a leading provider of 3D LiDAR solutions, is charting a new course in the enterprise physical security marketplace with the unveiling of a new business model and value proposition that reflects the vision of company CEO, Enzo Signore.

Key Points: 
  • “Quanergy was founded on the belief that security needs to be more intelligent, more accurate and more proactive to serve its purpose in today’s dynamic environments,” said Signore.
  • Moreover, today’s systems are designed primarily as forensic tools to support security operations after a crime has already been committed.
  • Mark Heintzman, Head of Technical Partnerships, Hanwha Vision, said: “Quanergy has a very strong, unique solution in the market.
  • Core applications include: PIDS (perimeter intrusion detection); fence, wall, and rooftop protection; tailgating prevention; server rack protection; asset protection; footfall analysis; space utilization; and business operations efficiency.

New England Life Care Selects DoseMe to Support New Initiatives Around Compliance Protocols

Retrieved on: 
Thursday, August 3, 2023

New England Life Care is nationally recognized as a nonprofit, mission-driven home infusion therapy and specialty pharmacy services provider affiliated with 60+ of New England’s premier medical centers.

Key Points: 
  • New England Life Care is nationally recognized as a nonprofit, mission-driven home infusion therapy and specialty pharmacy services provider affiliated with 60+ of New England’s premier medical centers.
  • “As a home infusion pharmacy, NELC wanted to make sure we were prepared to support our member hospitals when instituting new procedures and protocols related to the new vancomycin guidelines, released in 2020,” stated Erica Sievert, Regional Director of Pharmacy for New England Life Care.
  • New England Life Care is using DoseMeRx’s clinical decision support software to dose vancomycin and aminoglycosides.
  • “We are thrilled to be working with the team at New England Life Care to better serve their patients while staying ahead of guidelines and protocols,” said John Hardesky, CCO of DoseMe.

Cincoze DX-1200 Industrial Computer Powers Multiple Railway Computing Applications

Retrieved on: 
Thursday, July 27, 2023

The integration of industrial computers in railway applications has been a significant development contributing to railway safety through the railway detection system, passenger convenience through passenger information display systems (PIDS), and personal safety through in-car surveillance.

Key Points: 
  • The integration of industrial computers in railway applications has been a significant development contributing to railway safety through the railway detection system, passenger convenience through passenger information display systems (PIDS), and personal safety through in-car surveillance.
  • Cincoze's latest addition to the Rugged Computing - DIAMOND product line, the efficient and compact DX-1200 embedded industrial computer, is an excellent choice for these railway computing applications due to its high efficiency, stable operation, wide temperature support, expandability, and rich I/O.
  • Optional M12 connectors (A-coded and X-coded) are also available to meet the requirements of railway computing applications.
  • The DX-1200 has passed the US military specification MIL-STD-810G, showing excellent performance in withstanding shock and vibration in the railway environment.

$97.3 Billion Worldwide Perimeter Intrusion Detection Systems Industry to 2027 - Players Include Anixter International, Axis Communications, Cias Elettronica and Detekion Security Systems

Retrieved on: 
Wednesday, January 18, 2023

The global perimeter intrusion detection systems market size reached US$ 41.7 Billion in 2021.

Key Points: 
  • The global perimeter intrusion detection systems market size reached US$ 41.7 Billion in 2021.
  • What is the breakup of the global perimeter intrusion detection systems market based on the deployment type?
  • What are the key regions in the global perimeter intrusion detection systems market?
  • 9. Who are the key players/companies in the global perimeter intrusion detection systems market?

Global Perimeter Intrusion Detection Systems Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 12, 2023

A perimeter intrusion detection system (PIDS) is used to detect, track and monitor an unauthorized physical intruder attempting to breach the privacy of a secured area.

Key Points: 
  • A perimeter intrusion detection system (PIDS) is used to detect, track and monitor an unauthorized physical intruder attempting to breach the privacy of a secured area.
  • It comprises sensors, wires and active infrared or microwave systems that are either fence mounted or buried underground.
  • The publisher provides an analysis of the key trends in each sub-segment of the global perimeter intrusion detection systems market report, along with forecasts at the global, regional and country level from 2022-2027.
  • Our report has categorized the market based on component, deployment type and vertical.

Senstar Technologies to Report Third Quarter 2022 Results on Thursday, December 22, 2022

Retrieved on: 
Thursday, December 15, 2022

A replay of the call will be available on December 22, 2022, after 1:00 pm Eastern time through January 5, 2023, at 11:59 pm Eastern time, and available on the Senstar Technologies website at https://senstartechnologies.com/earnings-calls/ .

Key Points: 
  • A replay of the call will be available on December 22, 2022, after 1:00 pm Eastern time through January 5, 2023, at 11:59 pm Eastern time, and available on the Senstar Technologies website at https://senstartechnologies.com/earnings-calls/ .
  • Senstar is a global leader in innovative perimeter intrusion detection systems (PIDS) and intelligent video management (VMS) with advanced video analytics and access control, offering a comprehensive suite of innovative, intelligent, integrated security technologies.
  • Senstar offers a comprehensive suite of proven, integrated technologies that reduce complexity, improve performance and unify support.
  • Senstar, which products are found in thousands of sites including critical infrastructure, logistics, corrections and energy, has been protecting high risk assets for more than 40 years.

Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022

Retrieved on: 
Wednesday, October 19, 2022

Atukunda and Boulware will present the EnACT Phase 2 abstract on Friday, October 21st at the Walter E. Washington Convention Center, in Washington DC.

Key Points: 
  • Atukunda and Boulware will present the EnACT Phase 2 abstract on Friday, October 21st at the Walter E. Washington Convention Center, in Washington DC.
  • IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS) and the Society of Infectious Diseases Pharmacists (SIDP).
  • Matinas BioPharma is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology.
  • Matinas BioPharmas product candidates are all in a development stage and are not available for sale or use.

Qpex Biopharma Announces Presentations on Phase 1 and Nonclinical Data on Three Clinical Stage Oral and IV Products Targeting Antibiotic-Resistant Bacterial Infections at 2022 ID Week Meeting

Retrieved on: 
Monday, October 17, 2022

Qpex Biopharma today announced that clinical and preclinical data on its portfolio of clinical stage investigational antibiotic programs will be featured in several presentations at the upcoming 2022 ID Week Meeting in Washington, DC on October 19-23.

Key Points: 
  • Qpex Biopharma today announced that clinical and preclinical data on its portfolio of clinical stage investigational antibiotic programs will be featured in several presentations at the upcoming 2022 ID Week Meeting in Washington, DC on October 19-23.
  • The presentations will describe progress on three Qpex investigational products that the recent WHO pipeline analysis identified as addressing drug-resistant pathogens for which there is a critical need for new drugs.
  • QPX9003: a next-generation, IV-administered synthetic lipopeptide with an enhanced therapeutic profile designed to focus on highly drug-resistant infections caused by Pseudomonas and Acinetobacter.
  • The company also has a partnership with Brii Biosciences for the development and commercialization of three of its products in greater China.

Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022

Retrieved on: 
Thursday, October 13, 2022

Menlo Park, California, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) and its product candidate, ridinilazole, will have an oral podium presentation and a poster presentation at IDWeek 2022.

Key Points: 
  • Menlo Park, California, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) and its product candidate, ridinilazole, will have an oral podium presentation and a poster presentation at IDWeek 2022.
  • In the Ri-CoDIFy study, ridinilazole resulted in a meaningful reduction in the rate of recurrence of C. diff.
  • infection (8.1% vs 17.3%) and achieved a numerically higher sustained clinical response1 rate (73.0% vs 70.7%) than vancomycin.
  • We are pleased to inform that the results of our clinical study validated the assertions of Drs.